Blood Cell Crashes After CAR-T Therapy Follow a Predictable Risk Score, Study Finds
A retrospective cohort study of 96 patients shows the CAR-HEMATOTOX score predicts severe neutropenia and thrombocytopenia after CAR-T cell therapy, ...
A retrospective cohort study of 96 patients shows the CAR-HEMATOTOX score predicts severe neutropenia and thrombocytopenia after CAR-T cell therapy, ...
Chimeric antigen receptor T cell therapy has redefined the treatment of multiple myeloma, offering deep and durable remissions to patients ...
A longitudinal study of 155 lymphoma patients found that older adults recovered memory function after CAR T-cell therapy while younger ...
New awards from the AACR, Department of Defense and National Cancer Institute will fund enhancer hub research, ovarian cancer immunotherapy, ...
A new Oncoscience perspective maps the 2025–2026 glioblastoma clinical trial pipeline across four mechanistic domains, showing how biomarker-guided selection and ...
New MD Anderson studies report a Phase 3 immunotherapy advance in EGFR-mutant lung cancer, a dual role for B7-H3 in ...
A new MD Anderson study finds that pre-existing immune rejection and the intrinsic fitness of donor-derived CAR T cells determine ...
UChicago Medicine has launched a first-of-its-kind investigator-initiated clinical trial of a fully on-site manufactured T-cell receptor therapy engineered to target ...
The clinical case for expanding access to CAR T-cell therapy in Brazil rests on a substantial body of evidence demonstrating ...
The systematic review by Mahmoudi and colleagues arrives at a moment when the field of CAR T-cell therapy is confronting ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine